Casp8 Cancer Research Results
Casp8, CASP8, caspase 8, apoptosis-related cysteine peptidase: Click to Expand ⟱
| Source: CGL-Driver Genes |
| Type: TSG |
Caspase-8 is a unique member of caspases with a dual role in cell death and survival. Caspase-8 expression is often lost in some tumors, but increased in others, indicating a potential pro-survival function in cancer.
Caspase-8 (Casp8) acts as an initiator in cell apoptosis signaling. However, the role of Casp8 in tuning the tumor immune microenvironment remains controversial due to the complicated crosstalk between immune-tolerogenic apoptotic cell death and immunogenic cell death cascades.
|
Scientific Papers found: Click to Expand⟱
| - |
in-vitro, |
Colon, |
HCT116 |
|
|
|
CycB/CCNB1↓,
cDC2↓,
CDC25↓,
P53↑,
P21↑,
cl‑PARP↑, cleavage
proCasp8↓, Apigenin induced poly (ADP-ribose) polymerase (PARP) cleavage and decreased the levels of procaspase-8, -9 and -3
proCasp9↓,
proCasp3↓,
eff↑, chlorophyllin-assisted photodynamic therapy significantly induced cytotoxicity
ROS↑, In addition, reactive oxygen species generation and Annexin V expression level were detected on the photodynamic reaction-treated HeLa cells under the optimized conditions to evaluate apoptosis using a fluorescence microscope.
Casp8↓, the photodynamic therapy group showed the increased protein expression level of the cleaved caspase 8, caspase 9, Bax, and cytochrome C, and the suppressed protein expression level of Bcl-2, pro-caspase 8, and pro-caspase 9.
Casp9↑,
BAX↑,
Cyt‑c↑,
Bcl-2↓,
AKT1↓, the proposed photodynamic therapy downregulated the phosphorylation of AKT1 in the HeLa cells.
| - |
in-vitro, |
BC, |
MDA-MB-231 |
|
|
|
- |
in-vitro, |
Nor, |
MCF10 |
|
|
|
eff↑, MTT assays revealed that the ethyl acetate fraction exhibited the strongest inhibitory effect on cell proliferation.
selectivity↑, 12 potential active compounds, including sesquiterpenes such as Isoalantolactone and Artemisinin, which showed significantly lower toxicity toward normal mammary epithelial MCF-10A cells compared to tumor cells (
Apoptosis↑, the extract induced apoptosis in a dose-dependent manner, with an apoptosis rate as high as 85.04%, and significantly arrested the cell cycle at the S and G2/M phases
TumCCA↑,
PI3K↓, antitumor effects were primarily mediated through the regulation of PI3K-Akt (hsa04151), JAK-STAT (hsa04630), and PPAR (hsa03320) signaling pathways.
Akt↓, these active compounds exhibited strong binding affinities with key target proteins such as PI3K and JAK1
JAK1↓,
STAT↓,
PPARγ↑, EA-2 may remodel tumor cell lipid metabolism by activating the PPARγ pathway
TumCP↓, EA-2 Inhibits the Proliferation of MDA-MB-231 Breast Cancer Cells In Vitro
SIRT6↓, PI3K, AKT1S1, SIRT6, JAK1, SCD, STAT3, CASP8, STAT6, PAK1, and FABP4—were significantly downregulated.
SCD1↓,
STAT3↓,
Casp8↓,
STAT6↓,
PAK1↓,
FABP4↓,
| - |
Review, |
Var, |
NA |
|
|
|
- |
Review, |
AD, |
NA |
|
|
|
Beclin-1↑, EGCG not only regulates autophagy via increasing Beclin-1 expression and reactive oxygen species generation,
ROS↑,
Apoptosis↑, Apoptosis is a common cell function in biology and is induced by endoplasmic reticulum stress (ERS)
ER Stress↑,
*Inflam↓, EGCG has health benefits including anti-tumor [15], anti-inflammatory [16], anti-diabetes [17], anti-myocardial infarction [18], anti-cardiac hypertrophy [19], anti-atherosclerosis [20], and antioxidant
*cardioP↑,
*antiOx↑,
*LDL↓, These effects are mainly related to (LDL) cholesterol inhibition, NF-κB inhibition, MPO activity inhibition, decreased levels of glucose and glycated hemoglobin in plasma, decreased inflammatory markers, and reduced ROS generation
*NF-kB↓,
*MPO↓,
*glucose↓,
*ROS↓,
ATG5↑, EGCG induced autophagy by enhancing Beclin-1, ATG5, and LC3B and promoted mitochondrial depolarization in breast cancer cells.
LC3B↑,
MMP↑,
lactateProd↓, 20 mg kg−1 EGCG significantly decreased glucose, lactic acid, and vascular endothelial growth factor (VEGF) levels
VEGF↓,
Zeb1↑, (20 uM) inhibited the proliferation through activating autophagy via upregulating ZEB1, WNT11, IGF1R, FAS, BAK, and BAD genes and inhibiting TP53, MYC, and CASP8 genes in SSC-4 human oral squamous cells [
Wnt↑,
IGF-1R↑,
Fas↑,
Bak↑,
BAD↑,
TP53↓,
Myc↓,
Casp8↓,
LC3II↑, increasing the LC3-II expression levels and induced apoptosis via inducing ROS in mesothelioma cell lines,
NOTCH3↓, but also could reduce partially Notch3/DLL3 to reduce drug-resistance and the stemness of tumor cells
eff↑, In combination therapies, low-intensity pulsed electric field (PEF) can improve EGCG to affect tumor cells; ultrasound (US) with tumor cells is the application of physical stimulation in cancer therapy.
p‑Akt↓, 20 μM EGCG increased intracellular ROS levels and LC3-II, and inhibited p-Akt in PANC-1 cells
PARP↑, 100 μM EGCG increased LC3-II, activated caspase-3 and PARP, and reduced p-Akt in HepG2
*Cyt‑c↓, EGCG protected neuronal cells against human viruses by inhibiting cytochrome c and Bax translocations, and reducing autophagy with increased LC3-II expression and decreased p62 expression
*BAX↓,
*memory↑, EGCG restored autophagy in the mTOR/p70S6K pathway to weaken memory and learning disorders induced by CUMS
*neuroP↑, Finally, EGCG increased the neurological scores through inhibiting cell death
*Ca+2?, EGCG treatment, [Ca2+]m and [Ca2+]i expressions were reduced and oxyhemoglobin-induced mitochondrial dysfunction lessened.
GRP78/BiP↑, MMe cells with EGCG treatment improved GRP78 expression in the endoplasmic reticulum, and induced EDEM, CHOP, XBP1, and ATF4 expressions, and increased the activity of caspase-3 and caspase-8.
CHOP↑, GRP78 accumulation converted UPR of MMe cells into pro-apoptotic ERS
ATF4↑,
Casp3↑,
Casp8↑,
UPR↑,
AntiTum↑, the antitumour and cancer preventive properties of alpha-santalol have been shown to involve cell death induction through apoptosis and cell cycle arrest in various cancer models.
Apoptosis↑,
TumCCA↑,
*Inflam↓, marked decrease in inflammatory markers have also been shown with alpha-santalol administration in skin tissue models
selectivity↑, regarding its toxicity, it was concluded that alpha-santalol is less toxic to normal breast epithelial cells (MCF-10A) than to breast cancer cells (MCF-7) (
tumCV↓, proliferation of both cell lines was reduced, but viability was decreased only in cancer cells.
Casp8↓, alpha-santalol induced extrinsic and intrinsic pathways of apoptosis in both cells with activation of caspase-8, 9 and cause dactivation of the executioner caspase-6, 7 in MCF-7 cells and caspase-3, and 6 in MDA-MB-231 cells along with PARP cleavage
Casp9↓,
Casp6↓,
Casp3↓,
cl‑PARP↑,
angioG↓, alpha-santalol inhibits angiogenesis by targeting VEGFR2 regulated AKT/mTOR/P70S6 K signalling pathway and as a result, suppresses tumour growth
VEGFR2↓,
Akt↑,
mTOR↓,
TumCG↓,
*GSTs↑, sandalwood oil on liver function by measuring the activity of glutathione S-transferase (GST) and levels of soluble sulphyduryl found that feeding of 5 μL of sandalwood oil to mice for 10 and 20 days produced a 1.80 and 1.93-fold increase in GST
*antiOx↑, antioxidant and free radical scavenging effects are well documented with methanolic extracts of sandalwood at different doses
*ROS↓,
Showing Research Papers: 1 to 5 of 5
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 5
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
ROS↑, 2,
Mitochondria & Bioenergetics(tgid=3) ⓘ
CDC25↓, 1, MMP↑, 1,
Core Metabolism/Glycolysis(tgid=4) ⓘ
AKT1↓, 1, FABP4↓, 1, lactateProd↓, 1, PPARγ↑, 1, SCD1↓, 1,
Cell Death(tgid=5) ⓘ
Akt↓, 1, Akt↑, 1, p‑Akt↓, 1, Apoptosis↑, 3, BAD↑, 1, Bak↑, 1, BAX↑, 1, Bcl-2↓, 1, Casp3↓, 1, Casp3↑, 1, proCasp3↓, 1, Casp6↓, 1, Casp8↓, 4, Casp8↑, 1, proCasp8↓, 1, Casp9↓, 1, Casp9↑, 1, proCasp9↓, 1, Cyt‑c↑, 1, Fas↑, 1, Myc↓, 1,
Transcription & Epigenetics(tgid=7) ⓘ
tumCV↓, 1,
Protein Folding & ER Stress(tgid=8) ⓘ
CHOP↑, 1, ER Stress↑, 1, GRP78/BiP↑, 1, UPR↑, 1,
Autophagy & Lysosomes(tgid=9) ⓘ
ATG5↑, 1, Beclin-1↑, 1, LC3B↑, 1, LC3II↑, 1,
DNA Damage & Repair(tgid=10) ⓘ
P53↑, 1, PARP↑, 1, cl‑PARP↑, 2, SIRT6↓, 1, TP53↓, 1,
Cell Cycle & Senescence(tgid=11) ⓘ
CycB/CCNB1↓, 1, P21↑, 1, TumCCA↑, 2,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
cDC2↓, 1, IGF-1R↑, 1, mTOR↓, 1, NOTCH3↓, 1, PI3K↓, 1, STAT↓, 1, STAT3↓, 1, STAT6↓, 1, TumCG↓, 1, Wnt↑, 1,
Migration(tgid=13) ⓘ
PAK1↓, 1, TumCP↓, 1, Zeb1↑, 1,
Angiogenesis & Vasculature(tgid=14) ⓘ
angioG↓, 1, ATF4↑, 1, VEGF↓, 1, VEGFR2↓, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
JAK1↓, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
eff↑, 3, selectivity↑, 2,
Clinical Biomarkers(tgid=22) ⓘ
Myc↓, 1, TP53↓, 1,
Functional Outcomes(tgid=23) ⓘ
AntiTum↑, 1,
Total Targets: 69
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
antiOx↑, 2, GSTs↑, 1, MPO↓, 1, ROS↓, 2,
Core Metabolism/Glycolysis(tgid=4) ⓘ
glucose↓, 1, LDL↓, 1,
Cell Death(tgid=5) ⓘ
BAX↓, 1, Cyt‑c↓, 1,
Migration(tgid=13) ⓘ
Ca+2?, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
Inflam↓, 2, NF-kB↓, 1,
Functional Outcomes(tgid=23) ⓘ
cardioP↑, 1, memory↑, 1, neuroP↑, 1,
Total Targets: 14
Scientific Paper Hit Count for: Casp8, CASP8, caspase 8, apoptosis-related cysteine peptidase
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:44 State#:% Dir#:1
wNotes=on sortOrder:rid,rpid
Home Page